Nome |
# |
Omalizumab in chronic spontaneous urticaria: Efficacy, safety, predictors of treatment outcome, and time to response., file de3e52b1-c2fc-762d-e053-3705fe0a30e0
|
11
|
Alexithymia in an unconventional sample of Forestry Officers: a Clinical Psychological study with surprising results, file de3e52b5-2cfd-762d-e053-3705fe0a30e0
|
11
|
null, file de3e52b2-d7e2-762d-e053-3705fe0a30e0
|
7
|
Systemic nickel allergy syndrome: tips and tricks on how to be suspected and treated, file de3e52b3-0eb8-762d-e053-3705fe0a30e0
|
7
|
H1-Antihistamines for Allergic Diseases: Old Aged but Not Old-Fashioned Drugs, file dc565152-1c88-461d-b560-17a6e736b7be
|
6
|
Allergic rhinitis: the eligible candidate to mite immunotherapy in the real world, file de3e52b0-b638-762d-e053-3705fe0a30e0
|
6
|
Safety of sublingual immunotherapy in children, file de3e52af-48de-762d-e053-3705fe0a30e0
|
5
|
null, file de3e52b2-2a5f-762d-e053-3705fe0a30e0
|
5
|
Omalizumab: A useful tool for inducing tolerance to bee venom immunotherapy, file de3e52b2-d7d7-762d-e053-3705fe0a30e0
|
5
|
Impairment of sensory-motor plasticity in mild Alzheimer's disease, file de3e52af-93cd-762d-e053-3705fe0a30e0
|
4
|
null, file de3e52b1-9830-762d-e053-3705fe0a30e0
|
4
|
null, file de3e52b5-60bf-762d-e053-3705fe0a30e0
|
4
|
Omalizumab in Severe-Allergic Asthma:the Impact on Real Life Patients, file 507661b2-62c5-4e02-b8e7-3024a2775935
|
3
|
Systemic nickel allergy syndrome: epidemiological data from four Italian allergy units, file de3e52af-06bd-762d-e053-3705fe0a30e0
|
3
|
null, file de3e52b1-7b0b-762d-e053-3705fe0a30e0
|
3
|
null, file de3e52b1-bd49-762d-e053-3705fe0a30e0
|
3
|
Systemic nickel allergy syndrome: epidemiological data from four Italian allergy units, file de3e52b1-c655-762d-e053-3705fe0a30e0
|
3
|
Gluten-related disorders: certainties, questions and doubts, file de3e52b4-3c5c-762d-e053-3705fe0a30e0
|
3
|
null, file de3e52ae-b6c5-762d-e053-3705fe0a30e0
|
2
|
Olea sublingual allergoid immunotherapy administered with two different treatment regimens, file de3e52ae-bf80-762d-e053-3705fe0a30e0
|
2
|
Aluminium allergy in a patient with occupational contact dermatitis., file de3e52ae-c137-762d-e053-3705fe0a30e0
|
2
|
null, file de3e52ae-c140-762d-e053-3705fe0a30e0
|
2
|
null, file de3e52ae-c1c2-762d-e053-3705fe0a30e0
|
2
|
The adhesion molecule icam-1 is overexpressed in patients with hymenoptera venom allergy and decreases after ultrarush venom immunotherapy., file de3e52ae-d51a-762d-e053-3705fe0a30e0
|
2
|
null, file de3e52ae-e8eb-762d-e053-3705fe0a30e0
|
2
|
ASSISTENZA ALLA PERSONA CON DISTURBI IMMUNO-MEDIATI, file de3e52ae-f852-762d-e053-3705fe0a30e0
|
2
|
null, file de3e52b2-3db0-762d-e053-3705fe0a30e0
|
2
|
null, file de3e52b2-75e6-762d-e053-3705fe0a30e0
|
2
|
Probiotic supplementation in systemic nickel allergy syndrome patients: study of its effects on lactic acid bacteria population and on clinical symptoms, file de3e52b4-0c35-762d-e053-3705fe0a30e0
|
2
|
Omalizumab in middle-aged or older patients with severe
allergic asthma-COPD overlap, file de3e52b5-7c60-762d-e053-3705fe0a30e0
|
2
|
Alexithymia and asthma: a systematic review, file fdf9203f-716c-4df4-9214-1e660f7d7c14
|
2
|
Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both, file 0639ffc1-2089-45ef-8cd7-d95747c8ebea
|
1
|
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps, file 3359223b-23c6-48f7-b53d-d541d7ea4d34
|
1
|
Clinical Psychology and Clinical Immunology: is there a link between
Alexithymia and severe Asthma?, file 3d2c0b38-d91b-4a77-a7f0-78801615aad1
|
1
|
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus, file 557fe401-61d3-4e87-9a80-f633e3fa38ad
|
1
|
Arterial Stiffness and Adult Onset Vasculitis: A Systematic Review, file 93ca7d37-df5f-468b-a08a-80eac5027305
|
1
|
null, file abb2ae8e-62ba-4b81-8360-03d826eaca62
|
1
|
Prevalence of Autoimmune and Autoinflammatory Diseases in Chronic Urticaria: Pathogenetic, Diagnostic and Therapeutic Implications, file c78002ab-beea-4f91-ae19-562d1d52d379
|
1
|
null, file c97ac73d-44eb-4832-93ad-15594bc32f70
|
1
|
null, file cd6c9694-a540-48ce-9df5-d677b13b3776
|
1
|
null, file de3e52ae-b3d4-762d-e053-3705fe0a30e0
|
1
|
Ethylene oxide allergy in dialysis patients, file de3e52ae-b877-762d-e053-3705fe0a30e0
|
1
|
Serum levels of sICAM-1 in subjects affected by systemic nickel allergy syndrome, file de3e52ae-bc1f-762d-e053-3705fe0a30e0
|
1
|
null, file de3e52ae-c0d0-762d-e053-3705fe0a30e0
|
1
|
Systemic nickel allergy: oral desensitization and possible role of cytokines interleukins 2 and 10, file de3e52ae-f4ff-762d-e053-3705fe0a30e0
|
1
|
Sistema Immunitario: generalità e accertamento, file de3e52ae-f853-762d-e053-3705fe0a30e0
|
1
|
Treatmentn of non-IgE-mediated food hypersensitivity reactions due to nickel, file de3e52af-0672-762d-e053-3705fe0a30e0
|
1
|
null, file de3e52af-08a0-762d-e053-3705fe0a30e0
|
1
|
Allergen immunotherapy may exert an extra-anti-allergic activity in children., file de3e52af-08a1-762d-e053-3705fe0a30e0
|
1
|
Omalizumab: A useful tool for inducing tolerance to Bee Venom Immunotherapy, file de3e52af-8dbf-762d-e053-3705fe0a30e0
|
1
|
Is interleukin-22 a possible indicator of chronic heart failure's progression?, file de3e52b0-5446-762d-e053-3705fe0a30e0
|
1
|
Serum levels of protein oxidation products in patients with nickel allergy., file de3e52b0-5a60-762d-e053-3705fe0a30e0
|
1
|
Allergic response due to a para-amino compound, file de3e52b1-527f-762d-e053-3705fe0a30e0
|
1
|
Castleman Disease in a Patient with Common Variable Immunodeficiency, file de3e52b1-cf40-762d-e053-3705fe0a30e0
|
1
|
null, file de3e52b1-f49d-762d-e053-3705fe0a30e0
|
1
|
Adherence to omalizumab: A multicenter "real-world" study, file de3e52b2-f222-762d-e053-3705fe0a30e0
|
1
|
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI), file de3e52b3-c347-762d-e053-3705fe0a30e0
|
1
|
Characteristics and treatment regimens across ERS SHARP severe asthma registries, file de3e52b3-e1ac-762d-e053-3705fe0a30e0
|
1
|
Hymenoptera Venom Allergy: Management of children and adults in clinical practice, file de3e52b4-273f-762d-e053-3705fe0a30e0
|
1
|
null, file de3e52b4-ec65-762d-e053-3705fe0a30e0
|
1
|
Nickel sensitization influence on microbiota in allergic and non-allergic disorders: what's up?, file de3e52b5-2376-762d-e053-3705fe0a30e0
|
1
|
null, file de3e52b5-6b86-762d-e053-3705fe0a30e0
|
1
|
Totale |
150 |